Public signalCompany raiseAuto-indexed · Unverified
Solstice Oncology, Inc. raised $121.3M
Solstice Oncology, Inc.· BOSTON, US· Biotechnology· Filed Mar 9, 2026
Solstice Oncology, Inc. reported raising capital. Based in BOSTON, MASSACHUSETTS, US. First sale reported 2026-02-20. Automatically indexed from a public SEC EDGAR Form D filing. Details beyond the filing have not been verified.
Raised
$121.3M
Confidence90%
On the record
- Location
- BOSTON, US
- Sector
- Biotechnology
- Record type
- Company raise
- Stage
- Reported raised
- Amount raised
- $121.3M
- Target amount
- $298.4M
- Filing date
- Mar 9, 2026
- Issuer type
- operating company
Gaps in the record
- Valuation and deal terms are not on the public record
- No company website on record
- Investors are not disclosed
- Not yet claimed or verified by the company
Sources & provenance
“Operating company sold 121,260,306 USD under Reg D.”
View original filing (SEC EDGAR Form D)
Automatically indexed from SEC EDGAR Form D · filing dated Mar 9, 2026. Details beyond the filing have not been verified.
Tags
USCompanyBiotechnologyOver $100MCompany Raise
Are you associated with Solstice Oncology, Inc.?
This is an automatically discovered public record, not a verified company listing. Founders can claim it and replace inferred data with verified facts.
Claim this record